selinexor
Showing 1 - 25 of 83
EBV-Positive DLBCL, Nos Trial in Guangzhou, Shanghai (Selinexor, R-CHOP Protocol)
Recruiting
- EBV-Positive Diffuse Large B-Cell Lymphoma, Nos
- Selinexor
- R-CHOP Protocol
-
Guangzhou, Guangdong, China
- +1 more
Nov 10, 2022
Smoldering Multiple Myeloma Trial (Selinexor)
Not yet recruiting
- Smoldering Multiple Myeloma
- Selinexor
- (no location specified)
Oct 27, 2022
Amyloid, Amyloidosis, AL Amyloidosis Trial in New York (Selinexor, Dexamethasone)
Suspended
- Amyloid
- +2 more
- Selinexor
- Dexamethasone
-
New York, New YorkWeill Cornell Medicine - Multiple Myeloma Center
May 17, 2022
Multiple Myeloma in Relapse Trial in Aurora (Selinexor, Pomalidomide, Daratumumab)
Recruiting
- Multiple Myeloma in Relapse
- Selinexor
- +4 more
-
Aurora, ColoradoUniversity of Colorado Hospital
Dec 30, 2021
Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)
Recruiting
- Relapsed or Refractory Acute Myeloid Leukemia
- Selinexor
- +5 more
-
Taiyuan, Shanxi, ChinaTao Wang
Feb 9, 2023
Multiple Myeloma Trial in Shanghai (Selinexor, Thalidomide, Lenalidomide)
Recruiting
- Multiple Myeloma
- Selinexor
- +4 more
-
Shanghai, Shanghai, ChinaShanghai Changzheng Hospital
Mar 3, 2022
Solid Tumor Malignancy Trial in Hackensack (Selinexor, Irinotecan)
Withdrawn
- Solid Tumor Malignancy
- Selinexor
- Irinotecan
-
Hackensack, New JerseyJohn Theurer Cancer Center at HackensackUMC
Dec 14, 2021
Extramedullary Multiple Myeloma Trial in Wuhan (Selinexor, CT103A)
Recruiting
- Extramedullary Multiple Myeloma
- Selinexor
- CT103A
-
Wuhan, Hu Bei, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
May 17, 2022
Gliosarcoma, Newly Diagnosed, Glioblastoma Trial run by the National Cancer Institute (NCI) (Selinexor, Temozolomide, Generic
Recruiting
- Gliosarcoma
- +2 more
- Selinexor
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 7, 2022
Soft Tissue Sarcoma Trial in Toronto (Selinexor, Doxorubicin)
Completed
- Soft Tissue Sarcoma
- Selinexor
- Doxorubicin
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Nov 26, 2021
DLBCL, Not Otherwise Specified Trial in Chongqing (selinexor)
Recruiting
- Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
- selinexor
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
Mar 27, 2023
Metastatic Colorectal Cancer Trial in Los Angeles, Newark, Plantation (Selinexor, Pembrolizumab, Trifluridine)
Active, not recruiting
- Metastatic Colorectal Cancer
- Selinexor
- +3 more
-
Los Angeles, California
- +2 more
Jun 2, 2022
Multiple Myeloma Trial in Guangzhou (Selinexor, Bortezomib, Lenalidomide)
Recruiting
- Multiple Myeloma
- Selinexor
- +3 more
-
Guangzhou, Guangdong, China
- +3 more
Aug 16, 2022
CNS Lymphoma Trial in China (Selinexor, Rituximab, Methotrexate)
Not yet recruiting
- Central Nervous System Lymphoma
- Selinexor
- +2 more
-
Hefei, Anhui, China
- +4 more
Jan 26, 2023
MGMT-Methylated Glioblastoma, Recurrent Glioblastoma, IDH-Wildtype Trial (Selinexor, Temozolomide)
Not yet recruiting
- MGMT-Methylated Glioblastoma
- Recurrent Glioblastoma, IDH-Wildtype
- Selinexor
- Temozolomide
- (no location specified)
Jun 28, 2022
Endometrial Cancer Trial in Israel, United States (Selinexor, Matching Placebo for selinexor)
Recruiting
- Endometrial Cancer
- Selinexor
- Matching Placebo for selinexor
-
Miami Beach, Florida
- +6 more
Jan 31, 2023
Myeloma Multiple, Myeloma, Refractory Multiple Myeloma Trial in Brooklyn, New York (Selinexor, Clarithromycin, Pomalidomide)
Recruiting
- Myeloma Multiple
- +2 more
- Selinexor
- +3 more
-
Brooklyn, New York
- +1 more
Jan 20, 2022
Multiple Myeloma, Refractory Trial in Greece, Israel (Selinexor, Dexamethasone, Bortezomib)
Recruiting
- Multiple Myeloma, Refractory
- Selinexor
- +2 more
-
Patra, Achaia, Greece
- +15 more
Apr 4, 2022
Recurrent Histiocytic and Dendritic Cell Tumor, Recurrent Non-Hodgkin Lymphoma, Refractory Histiocytic and Dendritic Cell Tumor
Recruiting
- Recurrent Histiocytic and Dendritic Cell Neoplasm
- +3 more
- Choline Salicylate
- Selinexor
-
Rochester, MinnesotaMayo Clinic in Rochester
Apr 4, 2022
Advanced Alveolar Soft Part Sarcoma, Advanced Soft Tissue Sarcoma, Metastatic Alveolar Soft Part Sarcoma Trial run by the NCI
Recruiting
- Advanced Alveolar Soft Part Sarcoma
- +3 more
- Atezolizumab
- +2 more
-
Bethesda, Maryland
- +1 more
Jul 2, 2022
Sarcoma,Soft Tissue Trial in Barcelona, Madrid, Zaragoza (Selinexor)
Recruiting
- Sarcoma,Soft Tissue
- Selinexor
-
Barcelona, Spain
- +5 more
Nov 16, 2021
DLBCL Germinal Center B-Cell Type Trial in China (Selinexor, Rituximab, Cyclophosphamide)
Recruiting
- DLBCL Germinal Center B-Cell Type
- Selinexor
- +5 more
-
Guangzhou, Guangdong, China
- +5 more
Aug 16, 2022
AML, Adult Trial in Hangzhou, Shanghai, Wuhan (Selinexor, Azacitidine, Venetoclax)
Not yet recruiting
- AML, Adult
- Selinexor
- +2 more
-
Hangzhou, China
- +3 more
Feb 12, 2023
Refractory Multiple Myeloma Trial in United States (selinexor, carfilzomib, dexamethasone)
Recruiting
- Refractory Multiple Myeloma
- selinexor
- +2 more
-
Scottsdale, Arizona
- +4 more
Apr 1, 2022
B-cell Lymphoma Trial in Belgium, France (selinexor, Rituximab, Dexamethasone)
Completed
- B-cell Lymphoma
- selinexor
- +6 more
-
Bruxelles, Belgium
- +7 more
Dec 6, 2021